EditorialCreativeSportsCollectionsVideos
Prices
0Log in

Visual content for professionals.
800M+ images and videos.

Content Hub

  • Current Events
  • Pictures of the Year
  • Sports
  • Editorial
  • Creative
  • Collections
  • Videos

Offers

  • Prices & Packages
  • Promotions
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Content Research
  • Contract Photography
  • API & FTP Push
  • my-picturemaxx
  • Become a Partner

Company

  • About IMAGO
  • Careers
  • News

Help Center

  • FAQ
  • Contact Us
Legal NoticeTerms & ConditionsLicense InformationData PrivacyPrivacy Settings
© 2026 IMAGO
CEPICBAPLABVPA
  5. BioNTech plans to close several sites, archive images

BioNTech plans to close several sites, archive images

May 5, 2026

The following photos have been selected for you by the IMAGO picture desk on this topic. For more pictures please use the search function.

Images in this collection

  • BioNTech: Annual Financial Results The logo of the German biotechnology company BioNTech appears on the screen of a smartphone placed on a reflective surface onto which another of the company s logos is projected, in Creteil, France, on March 10, 2026, as the company releases its financial results for the fourth quarter and fiscal year 2025. Crà teil France Copyright: xSamuelxBoivinx originalFilename: boivin-notitle260310_np1pE.jpg

    BioNTech: Annual Financial Results The logo of the German biotechnology company BioNTech appears on the screen of a smartphone placed on a reflective surface onto which another of the company s logos is projected, in Creteil, France, on March 10, 2026, as the company releases its financial results for the fourth quarter and fiscal year 2025. Crà teil France Copyright: xSamuelxBoivinx originalFilename: boivin-notitle260310_np1pE.jpg

  • Das BioNTech-Logo erscheint auf dem Bildschirm mit einer medizinischen Spritze in dieser Fotoillustration in Ontario, Kanada, am 3. Februar 2026. The BioNTech logo appears on the screen with a medical syringe in this photo illustration in Ontario, Canada, on February 3, 2026 (License=RM) Copyright: xZoonar.com RafaelxHenriquexdaxSilvax 24626605

    Das BioNTech-Logo erscheint auf dem Bildschirm mit einer medizinischen Spritze in dieser Fotoillustration in Ontario, Kanada, am 3. Februar 2026. The BioNTech logo appears on the screen with a medical syringe in this photo illustration in Ontario, Canada, on February 3, 2026 (License=RM) Copyright: xZoonar.com RafaelxHenriquexdaxSilvax 24626605

  • Mainz Chancellor Merzs inaugural visit to Rhineland-Palatinate Ugur Sahin Managing Director of Biontech r and Özlem Türeci Medical Director of Biontech, during Chancellor Merzs inaugural visit to Rhineland-Palatinate at the TRON research institute in Mainz, 09 12 2025 Copyright: xEibner-Pressefoto FlorianxWiegandx EP_FWD

    Mainz Chancellor Merzs inaugural visit to Rhineland-Palatinate Ugur Sahin Managing Director of Biontech r and Özlem Türeci Medical Director of Biontech, during Chancellor Merzs inaugural visit to Rhineland-Palatinate at the TRON research institute in Mainz, 09 12 2025 Copyright: xEibner-Pressefoto FlorianxWiegandx EP_FWD

  • BioNTech Covid-19 Vaccine manufacturing facility in Germany MARBURG, GERMANY - MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. Berlin Germany. Editorial use only. Please get in touch for any other usage. Copyright: x2025xAnadoluxAbdulhamidxHoÅübaÅüx

    BioNTech Covid-19 Vaccine manufacturing facility in Germany MARBURG, GERMANY - MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. Berlin Germany. Editorial use only. Please get in touch for any other usage. Copyright: x2025xAnadoluxAbdulhamidxHoÅübaÅüx

  • BioNTech Covid-19 Vaccine manufacturing facility in Germany MARBURG, GERMANY - MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. Berlin Germany. Editorial use only. Please get in touch for any other usage. Copyright: x2025xAnadoluxAbdulhamidxHoÅübaÅüx

    BioNTech Covid-19 Vaccine manufacturing facility in Germany MARBURG, GERMANY - MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. Berlin Germany. Editorial use only. Please get in touch for any other usage. Copyright: x2025xAnadoluxAbdulhamidxHoÅübaÅüx

  • Photo illustration in Canada - 13 Sep 2025 In this photo illustration, the BioNTech logo is seen displayed on a smartphone screen. Canada Copyright: xThomasxFullerx xSOPAxImagesx TFSPI_13092025-0589

    Photo illustration in Canada - 13 Sep 2025 In this photo illustration, the BioNTech logo is seen displayed on a smartphone screen. Canada Copyright: xThomasxFullerx xSOPAxImagesx TFSPI_13092025-0589

  • Original vials of all Comirnaty vaccines from BioNTech Pfizer Editorial Original vials of all Comirnaty vaccines from BioNTech Pfizer Copyright: xBEAUTIFULxSPORTS KJPetersx

    Original vials of all Comirnaty vaccines from BioNTech Pfizer Editorial Original vials of all Comirnaty vaccines from BioNTech Pfizer Copyright: xBEAUTIFULxSPORTS KJPetersx

  • Biontech, VoltAir office and commercial building complex, Alexanderstrasse, Mitte, Berlin, Germany

    Biontech, VoltAir office and commercial building complex, Alexanderstrasse, Mitte, Berlin, Germany

  • Covid 19 vaccine from Astra Zeneca, Moderna and Pfizer Biontech Pfizer Biontech The vaccine from Astra Zeneca, Moderna and Pfizer Biontech Pfizer Biontech against Corona Covid 19

    Covid 19 vaccine from Astra Zeneca, Moderna and Pfizer Biontech Pfizer Biontech The vaccine from Astra Zeneca, Moderna and Pfizer Biontech Pfizer Biontech against Corona Covid 19

  • BioNTech Berlin 29 12 2023 BioNTech Company sign on a commercial property in Berlin Mitte Biontech, the name was formed from Biopharmaceutical New Technologies Headquarters are in Mainz The company became known for the development of an mRNA vaccine for coronavirus prevention Berlin Berlin Berlin Berlin

    BioNTech Berlin 29 12 2023 BioNTech Company sign on a commercial property in Berlin Mitte Biontech, the name was formed from Biopharmaceutical New Technologies Headquarters are in Mainz The company became known for the development of an mRNA vaccine for coronavirus prevention Berlin Berlin Berlin Berlin

  • Annalena Baerbock Buendnis 90 Die Gruenen , Federal Foreign Minister, pictured at the inauguration ceremony for Biontechs mRNA vaccine production facility in Kigali, 18 12 2023 Baerbock travels to Rwanda for bilateral talks and to inaugurate the first mRNA vaccine production facility in Africa Kigali Rwanda Copyright: xFlorianxGaertnerx

    Annalena Baerbock Buendnis 90 Die Gruenen , Federal Foreign Minister, pictured at the inauguration ceremony for Biontechs mRNA vaccine production facility in Kigali, 18 12 2023 Baerbock travels to Rwanda for bilateral talks and to inaugurate the first mRNA vaccine production facility in Africa Kigali Rwanda Copyright: xFlorianxGaertnerx

  • former Behringwerke pharmaceutical manufacturer, today cluster of biotechnology companies like Biontech Marburg Hessen, Hesse Germany Lahntal

    former Behringwerke pharmaceutical manufacturer, today cluster of biotechnology companies like Biontech Marburg Hessen, Hesse Germany Lahntal

  • German Chancellor visits BioNTech on the occasion of the construction completion of the plasmid production in Marburg German Chancellor Olaf Scholz with Ugur Sahin, founder and CEO Biontech SE during his vi

    German Chancellor visits BioNTech on the occasion of the construction completion of the plasmid production in Marburg German Chancellor Olaf Scholz with Ugur Sahin, founder and CEO Biontech SE during his vi

  • German Chancellor visits BioNTech on the occasion of the constructional completion of the plasmid production in Marburg Ugur Sahin, founder and CEO Biontech SE left and

    German Chancellor visits BioNTech on the occasion of the constructional completion of the plasmid production in Marburg Ugur Sahin, founder and CEO Biontech SE left and

  • BIONTECH Headquarters in Marburg, MARBURG, GERMANY - 2021.02:13: BIONTECH Headquarters in MARBURG GERMANY HESSE. BioNTech, formed from English Biopharmaceutical New Technologies Biotechnology company based in Marburg., MARBURG, GERMANY - 2021.02:13: BIONTECH Headquarters in MARBURG GERMANY HESSE. BioNTech, formed from English Biopharmaceutical New Technologies Biotechnology company based in Marburg., 14.02.2021, Copyright: xColourx Panthermedia29612395.jpg

    BIONTECH Headquarters in Marburg, MARBURG, GERMANY - 2021.02:13: BIONTECH Headquarters in MARBURG GERMANY HESSE. BioNTech, formed from English Biopharmaceutical New Technologies Biotechnology company based in Marburg., MARBURG, GERMANY - 2021.02:13: BIONTECH Headquarters in MARBURG GERMANY HESSE. BioNTech, formed from English Biopharmaceutical New Technologies Biotechnology company based in Marburg., 14.02.2021, Copyright: xColourx Panthermedia29612395.jpg

  • 24 01 2021, xovx, economy, current affairs, Biontech produces Corona vaccine in Marburg Symbol photo Company logo Biontech on a company signpost at Behringwerke in Marburg, Biontech has been granted permission to operate its new p

    24 01 2021, xovx, economy, current affairs, Biontech produces Corona vaccine in Marburg Symbol photo Company logo Biontech on a company signpost at Behringwerke in Marburg, Biontech has been granted permission to operate its new p

  • The site of BioNTech Innovative Manufacturing Services GmbH in Idar Oberstein, photographed on Friday 18 12 2020 Biontech is one of the production sites of the Corona vaccine bub

    The site of BioNTech Innovative Manufacturing Services GmbH in Idar Oberstein, photographed on Friday 18 12 2020 Biontech is one of the production sites of the Corona vaccine bub

  • 18 12 2020, BioNTech plant in Idar Oberstein, Rhineland-Palatinate, A company headquarters of the vaccine manufacturer 18 12 2020, BioNTech plant in Idar Oberstein 18 12 2020, BioNTech plant in Idar Oberstein

    18 12 2020, BioNTech plant in Idar Oberstein, Rhineland-Palatinate, A company headquarters of the vaccine manufacturer 18 12 2020, BioNTech plant in Idar Oberstein 18 12 2020, BioNTech plant in Idar Oberstein

Collections
Curations